AF
PRAX icon

Allworth Financial’s Praxis Precision Medicines PRAX Stock Holding History

Allworth Financial’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.1K Buy
78
+3
+4% +$950 ﹤0.01% 2978
2026
Q1 		$24.2K Buy
75
+47
+168% +$14.5K ﹤0.01% 2853
2025
Q4 		$8.25K Buy
28
+16
+133% +$2.98K ﹤0.01% 3400
2025
Q3 		$636 Sell
12
-57
-83% -$2.76K ﹤0.01% 4375
2025
Q2 		$2.9K Buy
69
+63
+1,050% +$2.4K ﹤0.01% 3550
2025
Q1 		$216 Buy
+6
New +$375 ﹤0.01% 3858
2023
Q3 		– Sell
-42
Closed -$727 – 3525
2023
Q2 		$727 Hold
42
– – ﹤0.01% 2818
2023
Q1 		$512 Buy
+42
New +$1.77K ﹤0.01% 2835

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Allworth Financial's PRAX Position: Q2 2026 in Review

Allworth Financial increased its Praxis Precision Medicines (PRAX) stake by 4% in Q2 2026, buying an estimated $950 and bringing the position to 78 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Allworth Financial first reported a position in PRAX in Q1 2023 and has held it in 8 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Allworth Financial held 78 shares of Praxis Precision Medicines worth $26.1K as of Q2 2026.
  • Allworth Financial bought 3 Praxis Precision Medicines shares in Q2 2026, an estimated $950.
  • Praxis Precision Medicines made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #2978 holding.
  • Allworth Financial first reported a position in Praxis Precision Medicines in Q1 2023 and has held it in 8 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.